ECP 2023 Final Programme

Sunday, 10 Sept 184 Industry Symposia e Saturday, 9 September 2023 LS-01 Industry Symposium 16:45–18:15 Liffey Hall 2 Exploring the future of homologous recombination deficiency testing (AstraZeneca) Chair: Michael Hubank, United Kingdom 001 16:45–16:50 Welcome and introduction Michael Hubank, United Kingdom 002 16:50–17:15 Keynote: Emerging role of digital pathology in breast cancer Speaker tbd 003 17:15–17:30 Update on decentralised genomic instability testing in ovarian cancer Michael Hubank, United Kingdom 004 17:30–17:45 What’s next for prostate cancer diagnos- tics? Arndt Hartmann, Germany 005 17:45–18:00 Q&A and Close Michael Hubank, United Kingdom e Sunday, 10 September 2023 LS-02 Industry Symposium 13:00–14:30 Liffey B No Patient Left Behind: Practical Consid- erations for the Identification of HER2- low Breast Cancer (Daiichi) Chair: Frédérique Penault-Llorca, France 001 13:00–13:05 Welcome and introduction Frédérique Penault-Llorca, France 002 13:05–13:25 Working together: What do Oncologists need from Pathologists? Christian Jackisch, Germany 003 13:25–13:45 A new era of breast cancer testing: Key practical considerations Caterina Marchiò, Italy 004 13:45–14:05 Looking to the future: How can new technologies assist us to better assess HER2? Roberto Salgado, Belgium 005 14:05–14:25 Interactive discussion (All Faculty) Frédérique Penault-Llorca, France 006 14:25–14:30 Wrap-up and meeting close Frédérique Penault-Llorca, France LS-03 Industry Symposium 13:00–14:30 Wicklow Hall 2 Precision medicine in uro-oncology: Unlocking the potential of biomarkers (Janssen Pharmaceutica NV) Chairs: Eva Compérat, Austria Henning Reis, Germany 001 Precision medicine: Utilising biomarker testing in bladder and prostate cancer Eva Compérat, Austria 002 Pathologist recap – Interactive Q&A (All Faculty) Henning Reis, Germany Saturday, 9 Sept